Amoxicillin
NDC Package 0143-9821-01
Package Information
Amoxicillin is used to treat a wide variety of bacterial infections. Marketed by Hikma Pharmaceuticals Usa Inc., this product is identified by NDC 0143-9821 and is authorized under FDA application ANDA205274.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0143 - Hikma Pharmaceuticals Usa Inc.
- 0143-9821 - Amoxicillin
- 0143-9821-01 - 100 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
- 0143-9821 - Amoxicillin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0143-9821-01 identifies a specific commercial package of 100 tablet, chewable in 1 bottle, plastic of Amoxicillin, labeled by Hikma Pharmaceuticals Usa Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hikma Pharmaceuticals Usa Inc. on July 31, 2021. The current certification is valid through July 31, 2021.
What are the primary indications for this medication?
Amoxicillin is used to treat a wide variety of bacterial infections. This medication is a penicillin-type antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Amoxicillin is also used with other medications to treat stomach/intestinal ulcers caused by the bacteria H. pylori and to prevent the ulcers from returning.
How is this Hikma Pharmaceuticals Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00143982101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.